Edition:
India

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

16.55USD
22 Jun 2018
Change (% chg)

$-0.55 (-3.22%)
Prev Close
$17.10
Open
$17.20
Day's High
$17.20
Day's Low
$16.25
Volume
426,890
Avg. Vol
83,200
52-wk High
$20.55
52-wk Low
$7.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.64 December 23 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.04 0.20 0.00 --
Quarter Ending Sep-18 5 0.04 0.20 0.00 --
Year Ending Dec-18 5 0.49 2.46 0.00 29.48
Year Ending Dec-19 5 62.58 135.00 4.97 54.61
Earnings (per share)
Quarter Ending Jun-18 5 -0.64 -0.61 -0.69 --
Quarter Ending Sep-18 5 -0.67 -0.61 -0.74 --
Year Ending Dec-18 5 -2.73 -2.52 -2.92 -1.01
Year Ending Dec-19 5 -0.62 1.54 -2.57 -0.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.05 0.00 0.05 100.00
Quarter Ending Dec-17 0.17 0.00 0.17 100.00
Quarter Ending Sep-17 0.17 0.30 0.13 79.36
Quarter Ending Jun-17 0.20 0.30 0.10 49.65
Quarter Ending Mar-17 0.15 0.30 0.15 102.85

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.04 0.04 0.05 0.05 --
Quarter Ending Sep-18 0.04 0.04 0.05 0.05 --
Year Ending Dec-18 0.49 0.50 0.62 0.67 29.48
Year Ending Dec-19 62.58 62.57 75.22 84.53 54.61

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 1 0 2 0
Earnings